The latest news from India's most respected business daily.Business StandardIndia's largest drug maker, Ranbaxy Laboratories bounced back 15 per cent to close at Rs 470.70 after the company's CEO, Malvinder Singh clarified that the deal with Japan's Daiichi Sankyo remains on track.
[visit website]